{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:29:34Z","timestamp":1789972174640,"version":"4.0.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC 103-2623-E-182-001-NU"],"award-info":[{"award-number":["NSC 103-2623-E-182-001-NU"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC 102-2314-B-182-049-MY3"],"award-info":[{"award-number":["NSC 102-2314-B-182-049-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC 100-2314-B-182A-092-MY3"],"award-info":[{"award-number":["NSC 100-2314-B-182A-092-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC 102-2221-E-007-021-MY2"],"award-info":[{"award-number":["NSC 102-2221-E-007-021-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3A0513"],"award-info":[{"award-number":["CMRPG3A0513"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG391514"],"award-info":[{"award-number":["CMRPG391514"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173503","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T13:38:53Z","timestamp":1488548333000},"page":"e0173503","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson\u2019s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging"],"prefix":"10.1371","volume":"12","author":[{"given":"Chi-Chang","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Ting","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Wei","family":"Ee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Huan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Tsung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ping","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Han","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-2601","authenticated-orcid":true,"given":"Shiaw-Pyng","family":"Wey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"DJ Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(01)06260-2","article-title":"Neurodegeneration: a failure of neuroregeneration?","volume":"358","author":"RJ Armstrong","year":"2001","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","article-title":"The pathogenesis of cell death in Parkinson\u2019s disease","volume":"66","author":"P Jenner","year":"2006","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"U Ungerstedt","year":"1968","journal-title":"Eur J Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"RK Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP","volume":"318","author":"A Schober","year":"2004","journal-title":"Cell Tissue Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11064-012-0909-8","article-title":"Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice","volume":"8","author":"K Liu","year":"2013","journal-title":"Neurochem Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1126\/science.275.5301.838","article-title":"Dopaminergic neurons protected from degeneration by GDNF gene therapy","volume":"275","author":"DL Choi-Lundberg","year":"1997","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.21489","article-title":"Functional models of Parkinson\u2019s disease: a valuable tool in the development of novel therapies","volume":"64","author":"P Jenner","year":"2008","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"W Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by Nmethyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"RS Burns","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"JW Langston","year":"1983","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","article-title":"Aromatic amino acids and modification of parkinsonism","volume":"276","author":"GC Cotzias","year":"1967","journal-title":"N Engl J Med"},{"key":"ref14","first-page":"171","article-title":"Parkinsonism and DOPA","volume":"81","author":"GC Cotzias","year":"1968","journal-title":"Trans Assoc Am Physicians"},{"key":"ref15","first-page":"56","article-title":"L-Dopa (L-3,4-dihydroxyphenylanine)\u2014its clinical effects in parkinsonism","volume":"93","author":"MD Yahr","year":"1968","journal-title":"Trans Am Neurol Assoc"},{"key":"ref16","first-page":"183","article-title":"Traitement de la maladie de Parkinson par la L-DOPA","volume":"98","author":"A Barbeau","year":"1969","journal-title":"Union Med Can"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of Parkinsonism--chronic treatment with L-dopa","volume":"280","author":"GC Cotzias","year":"1969","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","article-title":"Current approaches to the treatment of Parkinson\u2019s disease","volume":"4","author":"J Jankovic","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1248\/bpb.28.1762","article-title":"Neurotrophic effect of magnolol in the hippocampal CA1 region of Senescence-Accelerated Mice (SAMP1)","volume":"28","author":"N Matsui","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2006.03.035","article-title":"Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage","volume":"537","author":"YR Lin","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2009.09.107","article-title":"Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice","volume":"1305","author":"N Matsui","year":"2009","journal-title":"Brain Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000323872","article-title":"Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism","volume":"8","author":"HH Chen","year":"2011","journal-title":"Neurodegener Dis"},{"key":"ref23","first-page":"985157","article-title":"Magnolol protects against MPTP\/MPP+-induced toxicity via inhibition of oxidative stress in in vivo and in vitro models of Parkinson&apos;s disease","volume":"2012","author":"A Muroyama","year":"2012","journal-title":"Parkinsons Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","article-title":"Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease","volume":"26","author":"NI Bohnen","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref25","first-page":"237","article-title":"Imaging the vesicular monoamine transporter","volume":"86","author":"KA Frey","year":"2001","journal-title":"Adv Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00252-X","article-title":"Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL\/6) and -insensitive (CD-1) mouse strains","volume":"307","author":"M Kilbourn","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"ref27","first-page":"1920","article-title":"Lack of regional selectivity during the progression of Parkinson disease: Implications for pathogenesis","volume":"61","author":"CS Lee","year":"2004","journal-title":"Arch Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","article-title":"Age-specific progression of nigrostriatal dysfunction in Parkinson&apos;s disease","volume":"69","author":"R de la Fuente-Fern\u00e1ndez","year":"2011","journal-title":"Ann Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nucmedbio.2006.05.006","article-title":"Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters","volume":"33","author":"R Goswami","year":"2006","journal-title":"Nucl Med Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nucmedbio.2006.12.005","article-title":"Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET Imaging agent targeting vesicular monoamine transporters","volume":"34","author":"MP Kung","year":"2007","journal-title":"Nucl Med Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nucmedbio.2007.01.007","article-title":"Pharmacokinetics of [<sup>18<\/sup>F] fluoroalkyl derivatives of dihydrotetrabenazine (DTBZ) in rat and monkey brain","volume":"34","author":"MR Kilbourn","year":"2007","journal-title":"Nucl Med Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","article-title":"In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with <sup>18<\/sup>F-AV-133","volume":"51","author":"N Okamura","year":"2010","journal-title":"J Nucl Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2967\/jnumed.110.078196","article-title":"Whole-body biodistribution and radiation dosimetry of <sup>18<\/sup>F-FP-(+)-DTBZ (<sup>18<\/sup>F-AV-133): A novel vesicular monoamine transporter 2 imaging agent","volume":"51","author":"KJ Lin","year":"2010","journal-title":"J Nucl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.nucmedbio.2011.05.010","article-title":"Optimal scanning time window for <sup>18<\/sup>F-FP-(+)-DTBZ (<sup>18<\/sup>F-AV-133) summed uptake measurements","volume":"38","author":"KJ Lin","year":"2011","journal-title":"Nucl Med Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2967\/jnumed.113.121897","article-title":"In vivo detection of monoaminergic degeneration in early Parkinson disease by <sup>18<\/sup>F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET","volume":"55","author":"SC Lin","year":"2014","journal-title":"J Nucl Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","article-title":"Correlation of Parkinson disease severity and <sup>18<\/sup>F-DTBZ positron emission tomography","volume":"71","author":"IT Hsiao","year":"2014","journal-title":"JAMA Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson&apos;s disease","volume":"2","author":"V Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/syn.21572","article-title":"Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([<sup>18<\/sup>F]AV-133) in a MPTP-lesioned PD mouse model","volume":"66","author":"KT Chao","year":"2012","journal-title":"Synapse"},{"key":"ref39","unstructured":"Chen IJ, Lin KJ, Weng YH, Hsieh CJ, Chao KT, Tsao HH, et al. Construction and evaluation of 18F-AV-133 small-animal PET templates for spatial normalization of the mouse brain. The 11th International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases, March 06\u201310, 2013. Florence, Italy."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nucmedbio.2010.01.002","article-title":"Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenazine (AV-133) to the vesicular monoamine transporter type 2 in rats","volume":"37","author":"HH Tsao","year":"2010","journal-title":"Nucl Med Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuroimage.2008.12.060","article-title":"Validation of 4-[<sup>18<\/sup>F]-ADAM as a SERT imaging agent using micro-PET and autoradiography","volume":"45","author":"KH Ma","year":"2009","journal-title":"NeuroImage"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/elps.1150110503","article-title":"Autoradiography using storage phosphor technology","volume":"11","author":"RF Johnston","year":"1990","journal-title":"Electrophoresis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1248\/bpb.18.89","article-title":"Studies on the quantitative autoradiography. I. Radioluminography for quantitative autoradiography of <sup>14<\/sup>C","volume":"18","author":"N Motoji","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.410400609","article-title":"Presynaptic monoaminergic vesicles in Parkinson&apos;s disease and normal aging","volume":"40","author":"KA Frey","year":"1996","journal-title":"Ann Neurol"},{"key":"ref45","first-page":"1920","article-title":"Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis","volume":"61","author":"CS Lee","year":"2004","journal-title":"Arch Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2999(95)00594-3","article-title":"The vesicular monoamine transporter is not regulated by dopaminergic drug treatments","volume":"294","author":"T Vander Borght","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1523\/JNEUROSCI.16-10-03507.1996","article-title":"The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat","volume":"16","author":"JM Wilson","year":"1996","journal-title":"J Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e39041","DOI":"10.1371\/journal.pone.0039041","article-title":"PET imaging a MPTP-induced mouse model of Parkinson\u2019s disease using the fluoropropyl-dihydrotetrabenazine analog [<sup>18<\/sup>F]-DTBZ (AV-133)","volume":"7","author":"JS Toomey","year":"2012","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.1985.tb07120.x","article-title":"Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse","volume":"44","author":"H Hallman","year":"1985","journal-title":"J Neurochem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jnr.20114","article-title":"Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway","volume":"76","author":"MW Jakowec","year":"2004","journal-title":"J Neurosci Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0006-8993(00)02999-1","article-title":"Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity","volume":"887","author":"F Fornai","year":"2000","journal-title":"Brain Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.nucmedbio.2005.04.020","article-title":"Resolution, sensitivity and precision with autoradiography and small animal positron emission tomography: implications for functional brain imaging in animal research","volume":"32","author":"KC Schmidt","year":"2005","journal-title":"Nucl Med Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T04:42:46Z","timestamp":1568868166000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173503"}},"subtitle":[],"editor":[{"given":"Chin-Tu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173503","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]}}}